Compare EQNR & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQNR | MCK |
|---|---|---|
| Founded | 1972 | 1833 |
| Country | Norway | United States |
| Employees | 24140 | N/A |
| Industry | Integrated oil Companies | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.6B | 91.0B |
| IPO Year | N/A | 1995 |
| Metric | EQNR | MCK |
|---|---|---|
| Price | $32.03 | $784.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | $37.00 | ★ $952.92 |
| AVG Volume (30 Days) | ★ 3.5M | 987.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.08% | 0.40% |
| EPS Growth | N/A | ★ 49.22 |
| EPS | N/A | ★ 38.38 |
| Revenue | N/A | ★ $112,084,000,000.00 |
| Revenue This Year | $13.35 | $14.94 |
| Revenue Next Year | N/A | $8.21 |
| P/E Ratio | ★ $14.56 | $20.48 |
| Revenue Growth | N/A | ★ 3.11 |
| 52 Week Low | $22.26 | $637.00 |
| 52 Week High | $43.46 | $999.00 |
| Indicator | EQNR | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 32.92 | 56.73 |
| Support Level | $30.83 | $731.84 |
| Resistance Level | $41.57 | $800.36 |
| Average True Range (ATR) | 0.59 | 19.45 |
| MACD | -0.15 | 1.89 |
| Stochastic Oscillator | 12.65 | 80.34 |
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2025 (50% liquids) and ended 2025 with 5.2 billion barrels of proven reserves (45% liquids). Operations also include oil refineries and natural gas processing, marketing, and trading. The renewables portfolio includes offshore and onshore wind and solar, with total power generation of 5.65 TWh in 2025.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.